Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world, Clin. Liver Dis, vol.20, pp.205-214, 2016. ,
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease, Nutrients, vol.5, pp.1544-1560, 2013. ,
The natural course of non-alcoholic fatty liver disease, Int. J. Mol. Sci, vol.17, p.774, 2016. ,
Nonalcoholic fatty liver disease and risk of incident Type 2 diabetes: a meta-analysis, Diabetes Care, vol.41, pp.372-382, 2018. ,
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis, J. Hepatol, vol.65, pp.589-600, 2016. ,
Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders, Int. J. Cardiol, vol.201, pp.408-414, 2015. ,
Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications, J. Clin. Endocrinol. Metab, vol.98, pp.483-495, 2013. ,
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease, N. Engl. J. Med, vol.363, pp.1341-1350, 2010. ,
Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes, Clin. Sci, vol.131, pp.1905-1917, 1979. ,
Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins, Obesity (Silver Spring, Md.), vol.22, pp.1854-1859, 2014. ,
Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease, Gastroenterology, vol.146, pp.726-735, 2014. ,
Hepatocyte deletion of triglyceride-synthesis enzyme acyl CoA: diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice, Hepatology, vol.70, pp.1972-1985, 2019. ,
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Investig, vol.122, pp.2176-2194, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02649316
A lipidomic analysis of nonalcoholic fatty liver disease, Hepatology (Baltim., Md.), vol.46, pp.1081-1090, 2007. ,
Increase in long-chain polyunsaturated fatty acid n -6/n -3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease, Clin. Sci, vol.106, pp.635-643, 1979. ,
Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders, Hepatology (Baltim., Md.), vol.47, pp.1513-1523, 2008. ,
In vivo characterization of the liver fat (1)H MR spectrum, NMR Biomed, vol.24, pp.784-790, 2011. ,
Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat, NMR Biomed, vol.24, pp.238-245, 2011. ,
Ultrashort-TE stimulated echo acquisition mode (STEAM) improves the quantification of lipids and fatty acid chain unsaturation in the human liver at 7 T, NMR Biomed, vol.28, pp.1283-1293, 2015. ,
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Investig, vol.115, pp.1343-1351, 2005. ,
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a, Pediatr. Res, vol.63, pp.702-707, 2008. ,
A dual sugar challenge test for lipogenic sensitivity to dietary fructose, J. Clin. Endocrinol. Metab, vol.96, pp.861-868, 2011. ,
Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans, Am. J. Physiol. Endocrinol. Metab, vol.300, pp.321-326, 2011. ,
Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men, Diabetes, vol.54, pp.2694-2701, 2005. ,
Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state, Proc. Nutr. Soc, vol.78, pp.126-134, 2019. ,
Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation, Cell Metab, vol.26, p.396, 2017. ,
GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease, Gastroenterology, vol.155, p.1466, 2018. ,
Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis, Clin. Gastroenterol. Hepatol, vol.16, 1983. ,
Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo, Magn. Reson. Med, vol.9, pp.79-93, 1989. ,
In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time, Magn. Reson. Med, vol.41, pp.649-656, 1999. ,
Experimental method to eliminate frequency modulation sidebands in localized in vivo 1H MR spectra acquired without water suppression, Magn. Reson. Med, vol.51, pp.602-606, 2004. ,
In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated, Metab.: Clin. Exp, vol.45, pp.817-821, 1996. ,
A new air displacement method for the determination of human body composition, Med. Sci. Sports Exerc, vol.27, pp.1692-1697, 1995. ,
Body composition from fluid spaces and density: analysis of methods, Nutrition, vol.9, p.492, 1961. ,
The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma, J. Lipid Res, vol.53, pp.1690-1700, 2012. ,
The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue, Sci. Rep, vol.6, p.27688, 2016. ,
Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry, Anal. Biochem, vol.366, pp.59-70, 2007. ,
Influences of glucose loading and of injected insulin on hepatic glucose output, Ann. N. Y. Acad. Sci, vol.82, pp.420-430, 1959. ,